Clearwater, FLNCT07476339Now EnrollingIRB Ready

HIV -1 Infection Clinical Trial in Clearwater, FL

Access cutting-edge hiv -1 infection treatment through this clinical trial at a research site in Clearwater. Study-provided care at no cost to qualified participants.

Sponsored by CAN Community Health

Quick Self-Assessment

See if you qualify for this Clearwater location

Preparing your pre-screening questions…

Expert Care in Clearwater

Access hiv -1 infection specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related hiv -1 infection treatment provided free

Apply for This Clearwater Location

Check if you qualify for this hiv -1 infection clinical trial in Clearwater, FL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Clearwater

    Convenient for FL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Clearwater site if eligible
  4. 4Begin participation

About This HIV -1 Infection Study in Clearwater

Managing HIV well requires taking antiretroviral therapy (ART) every day, but many people living with HIV experience interruptions in their treatment. These pauses in medication can happen for many reasons, such as side effects, challenges with getting to the clinic, personal circumstances, stigma, or difficulties with everyday life. When HIV treatment is stopped, the viral load can increase, which may affect a person's health and make it easier for HIV to be passed on to others. Restarting treatment quickly after an interruption is important for both personal and public health. However, it can be difficult for people who miss doses to get back on treatment right away. There are often several steps and medical appointments required before restarting, such as waiting for lab results or reviewing medical history, which can cause further delays. These additional steps can make it even harder for people to re-engage and may discourage them from returning to care. The REINITIATE study is designed for people living with HIV who have not taken any antiretroviral medications for at least the last 12 weeks. The study will offer participants a way to restart their HIV therapy quickly, by beginning treatment with B/F/TAF on the same day that they return to care. B/F/TAF is a widely used, once-daily HIV regimen, and is recommended in national treatment guidelines. Researchers want to find out if this rapid restart approach is safe and effective, and whether it helps people regain control of HIV and remain in care. The study will also examine how many participants are able to keep the virus at a low level (viral suppression), stay engaged in their HIV care, and tolerate the medication after rapidly restarting treatment. In addition, the study will include interviews with some participants, to gain a better understanding of why they stopped taking their medications and what supported their return to treatment. These insights could help healthcare teams develop better ways to support people living with HIV in the future.

Sponsor: CAN Community Health

Who Can Participate

Inclusion Criteria

≥18 years of age at the time of signing the informed consent form (ICF)
Diagnosis of HIV-1 confirmed by any positive HIV 4th generation test or detectable HIV-1 RNA level in \>6 months
Previously received ART for ≥30 consecutive days, as self-reported
No ART dose received for ≥12 weeks prior to provision of informed consent, by any route of administration (i.e., injection or oral), as self-reported
Returning to care with an interest to restart ART therapy
Body weight ≥55.12lbs (25 kg)
Signed ICF as described in the protocol which includes compliance with the requirements and restrictions listed in ICF and study protocol

Exclusion Criteria

Diagnosis of HIV-2 infection
Known or suspected history of severe hepatic impairment (Child-Pugh Class C)
Known or suspected history of severe renal impairment (estimated creatinine clearance \[eCrCl\] \<30 mL/min)
Concomitant medication that is contraindicated with B/F/TAF
Known or suspected resistance to BIC (resistance-associated mutations \[RAMs\] include: G118R, Y143C/H/R, Q148H/K/R, N155H/S, or R263K in the integrase gene)
Known/suspected resistance to tenofovir (TFV) (RAMs include: K65R/E/N, or K70E)
Known/suspected history of 3 or more thymidine analog mutation (TAMs) (M41L, D67N, K70R, L210W, T215F/Y, and K219Q/E/N/R), T69-insertions, or K65R/E/N in reverse transcriptase (RT)
History of B/F/TAF intolerance
Unable to swallow whole tablets or swallow tablets cut into halves
Unable to communicate in either English or Spanish

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Clearwater?

Yes, this clinical trial (NCT07476339) has an active research site in Clearwater, FL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

HIV -1 Infection Treatment Options in Clearwater, FL

If you're searching for hiv -1 infection treatment options in Clearwater, FL, this clinical trial (NCT07476339) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Clearwater research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hiv -1 infection specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all hiv -1 infection clinical trials near you to find additional studies recruiting in your area.

More HIV AIDS Trials in Clearwater, FL

See all hiv aids clinical trials recruiting in Clearwater — not just this study.

Browse HIV AIDS Trials in Clearwater

Browse More Trials by Condition

Ready to Join in Clearwater?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Clearwater, FL